Patient-Reported Outcomes and Quality of Life Improved with Fluticasone Propionate and Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhalers Versus Placebo in Patients with Persistent Asthma

被引：1
|
作者：
Raphael, Gordon [1 ]
Yiu, Gloria [2 ]
Sakov, Anat [3 ]
Liu, Siyu [2 ]
Caracta, Cynthia [2 ]
机构：
[1] Bethesda Allergy Asthma & Res Ctr, Bethesda, MD USA
[2] Teva Pharmaceut, Frazer, PA USA
[3] Teva Pharmaceut, Netanya, Israel
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 139卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2016.12.086
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
31
引用
收藏
页码：AB10 / AB10
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetic Bioequivalence of Two Fluticasone Propionate/Salmeterol Dry Powder Inhalers, OT329 Solis, and Advair Diskus
    Getz, Elise Burmeister
    Carroll, Kevin
    CHEST, 2017, 152 (04) : 768A - 768A
  • [42] Cost-Effectiveness Comparison of Salmeterol/Fluticasone Propionate versus Montelukast in the Treatment of Adults with Persistent Asthma
    Ketan Sheth
    Rohit Borker
    Amanda Emmett
    Kathleen Rickard
    Paul Dorinsky
    PharmacoEconomics, 2002, 20 : 909 - 918
  • [43] Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life
    Edin, Heather M.
    Andersen, Leslie B.
    Schoaf, Lynne
    Scott-Wilson, Catherine A.
    Ho, Shu-Yen
    Ortega, Hector G.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 102 (04) : 323 - 327
  • [44] Impact of fluticasone propionate powder on health-related quality of life in patients with moderate asthma
    Mahajan, P
    Okamoto, LJ
    Schaberg, A
    Kellerman, D
    Schoenwetter, WF
    JOURNAL OF ASTHMA, 1997, 34 (03) : 227 - 234
  • [45] Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma
    Galant, SP
    van Bavel, J
    Finn, A
    Gross, G
    Pleskow, W
    Brown, A
    Hamedani, AG
    Harding, SM
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (03) : 273 - 280
  • [46] Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma A Randomized Trial
    Woodcock, Ashley
    Bleecker, Eugene R.
    Lotvall, Jan
    O'Byrne, Paul M.
    Bateman, Eric D.
    Medley, Hilary
    Ellsworth, Anna
    Jacques, Loretta
    Busse, William W.
    CHEST, 2013, 144 (04) : 1222 - 1229
  • [47] Cost-Efficacy Analysis of Fluticasone Propionate versus Zafirlukast in Patients with Persistent Asthma
    Rogelio Menendez
    Richard H. Stanford
    Lisa Edwards
    Christopher Kalberg
    Kathleen Rickard
    PharmacoEconomics, 2001, 19 : 865 - 874
  • [48] Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthma
    Menendez, R
    Stanford, RH
    Edwards, L
    Kalberg, C
    Rickard, K
    PHARMACOECONOMICS, 2001, 19 (08) : 865 - 874
  • [49] Comparison of the clinical efficacy and safety of salmeterol/fluticasone propionate versus current care in the management of persistent asthma in Korea
    Jung, Ki-Suck
    Uh, Soo-Taek
    Lee, Yong-Chul
    Shim, Jae-Jeong
    Park, Soon-Kew
    Williams, Angela E.
    Chan, Robert
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (12) : 3571 - 3582
  • [50] ANALYSIS OF OUTCOMES AND COSTS FOR PERSISTENT ASTHMA PATIENTS TREATED WITH BECLOMETHASONE DIPROPIONATE OR FLUTICASONE PROPIONATE
    Gross, G.
    Lage, M. J.
    Brewster, C.
    Spalitto, A.
    VALUE IN HEALTH, 2009, 12 (03) : A123 - A123
12345